🔴 Kailera Therapeutics is trading 5% down today as biotech shares weakened broadly

Kailera Therapeutics is trading at $12.15, down 5.08%, as biotech shares weakened broadly on November 5.

• The biotech ETF XBI was also down sharply, consistent with sector-wide pressure.
• Kailera’s November 4 results reported a $95.7 million quarterly loss and $84.7 million in R&D spending; available reporting does not establish earnings as the direct trigger.